One hundred years have passed since the first paper on African swine fever (ASF) was published by Montgomery in 1921. With no vaccine, ineffectiveness of prevention and control measures and lack of common interest in eradicating the disease, ASF has proven to be one of the most devastating diseases because of its significant sanitary and socioeconomic consequences. The rapid spread of the disease on the European and Asian continents and its recent appearance in the Caribbean puts all countries at great risk because of global trade. The incidence of ASF has also increased on the African continent over the last few decades, extending its distribution far beyond the area in which the ancient sylvatic cycle is present with its complex epidemiological transmission pathways involving virus reservoirs in ticks and wild African Suidae. Both in that area and elsewhere, efficient transmission by infected domestic pigs and virus resistance in infected animal products and fomites mean that human driven factors along the pig value chain are the dominant impediments for its prevention, control and eradication. Control efforts in Africa are furthermore hampered by the lack of information about the size and location of the fast-growing pig population, particularly in the dynamic smallholder sector that constitutes up to 90% of pig production in the region. A vaccine that will be both affordable and effective against multiple genotypes of the virus is not a short-term reality. Therefore, a strategy for management of ASF in sub-Saharan Africa is needed to provide a roadmap for the way forward for the continent. This review explores the progression of ASF and our knowledge of it through research over a century in Africa, our current understanding of ASF and what must be done going forward to improve the African situation and contribute to global prevention and control.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/tbed.14466 | DOI Listing |
J Adolesc Health
January 2025
Center for Clinical Big Data and Statistics of the Second Affiliated Hospital Zhejiang University School of Medicine, School of Public Health Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Electronic address:
J Adolesc Health
January 2025
Division of Adolescent and School Health, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
Purpose: To examine differences in unstable housing and health-risk behaviors and experiences by sexual identity among U.S. high school students.
View Article and Find Full Text PDFJ Infect Dev Ctries
December 2024
Faculdade de Medicina de Campos, Campos dos Goytacazes, Brazil.
Introduction: Despite efforts by health organizations to share evidence-based information, fake news hindered the promotion of social distancing and vaccination during the coronavirus disease 2019 (COVID-19) pandemic. This study analyzed COVID-19 knowledge and practices in a vulnerable area in northern Rio de Janeiro, acknowledging the influence of the complex social and economic landscape on public health perceptions.
Methodology: This cross-sectional study was conducted in Novo Eldorado - a low-income, conflict-affected neighborhood in Campos dos Goytacazes - using a structured questionnaire, following the peak of COVID-19 deaths in Brazil (July-December 2021).
J Infect Dev Ctries
December 2024
Institute of Public Health, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Introduction: Significant challenges to implementing international health regulations (IHR) at points of entry (PoEs) have been highlighted by the coronavirus disease 2019 (COVID-19) pandemic. Better assessment of the capacities of the PoEs may promote focused interventions. This study aimed to assess the capacities and practices at PoEs.
View Article and Find Full Text PDFIntroduction: China implemented a dynamic zero-COVID strategy to curb viral transmission in response to the coronavirus disease 2019 (COVID-19) pandemic. This strategy was designed to inhibit mutation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19. This study explores the dynamics of viral evolution under stringent non-pharmaceutical interventions (NPIs) through real-world observations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!